Search results
Pfizer-Connect Biopharma deal for inflammatory drug ends
Seeking Alpha· 6 hours agoConnect Biopharma (CNTB) terminates licensing deal with Pfizer (PFE) for CBP-174, an oral...
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
FierceBiotech· 13 hours agoPfizer’s cost cuts that began last year have stretched to the closure of a well-known internal R&D...
Canaan hires Pfizer executive, reels in $100M for biotech investing
BioPharma Dive via Yahoo Finance· 14 hours agoThe firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist...
Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact
FierceBiotech· 13 hours agoConnect Biopharma is uncoupling from Pfizer, returning the rights to an eczema candidate it picked...
Lee Howard: What's Going On: Pfizer putting $20 million-plus into local renovations
The Day· 3 days agoFILE- A Pfizer logo is shown at their global supply Kalamazoo manufacturing plant in Portage, Mich.,...
Pfizer (NYSE:PFE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 21 hours agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued on Monday, Benzinga ...
VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science
FierceBiotech· 13 hours agoGeneral Partner Julie Grant told Fierce Biotech that the money will act as a designated pool for...
Pfizer Inc. (NYSE:PFE) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 2 days agoVontobel Holding Ltd. lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 27.0% in the fourth quarter, according to the company in its most recent filing ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 5 days ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
New Insider Trading Precedent: Time To Update Insider Trading Policy | JD Supra
JD Supra· 7 hours agoThe SEC’s complaint alleged that Panuwat used highly confidential information of his employer, Medivation, Inc.’s (“Medivation”) upcoming acquisition by Pfizer Inc. (“< ...